This inventor holds 1 USPTO granted patent. Top assignees: Unversität Zürich, Wayne State University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 276 
1 out of 603 
Years Active: 2022
Title: Girish Sati: Innovator in Antibacterial Drug Development
Introduction
Girish Sati is a notable inventor based in Detroit, MI (US). He has made significant contributions to the field of antibacterial drugs, particularly through his innovative work on aminoglycoside derivatives. His research focuses on enhancing the efficacy of existing antibacterial agents against resistant pathogens.
Latest Patents
Girish Sati holds a patent for "Neomycin and paromomycin derivatives." This patent relates to derivatives of neamine-based aminoglycoside antibacterial drugs modified in positions C6', C2', and/or C5''. The modifications introduced in his work impart favorable properties regarding activity against ESKAPE pathogens, evasion of resistance traits, and increased selectivity, enabling systemic use of the compounds.
Career Highlights
Throughout his career, Girish has worked with esteemed institutions such as Wayne State University and Universität Zürich. His research has focused on developing new antibacterial compounds that can effectively combat resistant bacterial strains.
Collaborations
Girish has collaborated with notable colleagues, including David Crich and Amr Sonousi, to advance his research in the field of antibacterial drug development.
Conclusion
Girish Sati's innovative work in the development of neomycin and paromomycin derivatives showcases his commitment to addressing the challenges posed by antibiotic resistance. His contributions are vital in the ongoing fight against resistant pathogens.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile